West Paces Advisors’s Belite Bio BLTE Stock Holding History

West Paces Advisors’s Portfolio BLTE Stock Details BLTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.06K	Hold	18	–	–	﹤0.01%	520
2026 Q2	$2.77K	Buy	+18	New	+$2.76K	﹤0.01%	537

Other funds holding BLTE

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

West Paces Advisors's BLTE Position: Q3 2026 in Review

West Paces Advisors held its Belite Bio (BLTE) position steady in Q3 2026 at 18 shares worth $3.06K. The position accounts for ﹤0.01% of the portfolio, ranked #520.

West Paces Advisors first reported a position in BLTE in Q2 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

West Paces Advisors held 18 shares of Belite Bio worth $3.06K as of Q3 2026.
West Paces Advisors left its Belite Bio share count unchanged in Q3 2026.
Belite Bio made up ﹤0.01% of West Paces Advisors's portfolio in Q3 2026, its #520 holding.
West Paces Advisors first reported a position in Belite Bio in Q2 2026 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.